SEATTLE – If you’re counting those in lasting remission from HIV, Dr. John Mellors of the University of Pittsburgh said here today, there’s been a doubling in their numbers. Now there are two. The dry tone of Mellor’s remarks, and the circumspect wording of Dr. Ravindra Gupta, the physician researcher of University College London, who he […]
Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — To put this in perspective, about 70 million […]
When Dr. Dan Kuritzkes of Harvard Medical School and Brigham and Women’s Hospital presented his team’s findings on two HIV-positive men who remained on antiretroviral therapy while undergoing stem cell transplants, and in whom the levels of HIV DNA had since dropped to undetectable levels, he was careful to emphasize that he was not claiming […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]